| Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment DO Croci, MF Zacarías Fluck, MJ Rico, P Matar, GA Rabinovich, ... Cancer immunology, immunotherapy 56, 1687-1700, 2007 | 281 | 2007 |
| Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy ME Beaulieu, T Jauset, D Massó-Vallés, S Martínez-Martín, P Rahl, ... Science translational medicine 11 (484), eaar5012, 2019 | 189 | 2019 |
| Constitutive HER2 signaling promotes breast cancer metastasis through cellular senescence PD Angelini, MFZ Fluck, K Pedersen, JL Parra-Palau, M Guiu, ... Cancer research 73 (1), 450-458, 2013 | 112 | 2013 |
| Patterns of HER2 gene amplification and response to anti-HER2 therapies R Vicario, V Peg, B Morancho, M Zacarias-Fluck, J Zhang, ... PloS one 10 (6), e0129876, 2015 | 59 | 2015 |
| Effect of cellular senescence on the growth of HER2-positive breast cancers MF Zacarias-Fluck, B Morancho, R Vicario, A Luque Garcia, ... Journal of the National Cancer Institute 107 (5), djv020, 2015 | 52 | 2015 |
| Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy JL Parra-Palau, B Morancho, V Peg, M Escorihuela, M Scaltriti, R Vicario, ... Journal of the National Cancer Institute 106 (11), dju291, 2014 | 51 | 2014 |
| The immune response and the therapeutic effect of metronomic chemotherapy with cyclophosphamide VR Rozados, LE Mainetti, MJ Rico, M Zacarías Fluck, P Matar, ... Cognizant Communication Corporation, 2010 | 39 | 2010 |
| Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model MF Zacarías Fluck, MJ Rico, SI Gervasoni, JM Ilarregui, MA Toscano, ... Cancer Immunology, Immunotherapy 56, 237-248, 2007 | 25 | 2007 |
| MYC inhibition halts metastatic breast cancer progression by blocking growth, invasion, and seeding D Massó-Vallés, ME Beaulieu, T Jauset, F Giuntini, MF Zacarías-Fluck, ... Cancer Research Communications 2 (2), 110-130, 2022 | 16 | 2022 |
| Regulatory T cells but not NKT I cells are modulated by a single low-dose Cyclophosphamide in a B cell lymphoma tumor-model MJ Rico, VR Rozados, LE Mainetti, MFZ Fluck, P Matar, OG Scharovsky Experimental Oncology 34 (1), 38-42, 2012 | 12 | 2012 |
| The Wnt signaling receptor Fzd9 is essential for Myc-driven tumorigenesis in pancreatic islets MF Zacarías-Fluck, T Jauset, S Martínez-Martín, J Kaur, ... Life science alliance 4 (5), 2021 | 8 | 2021 |
| The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide MF Zacarías Fluck, L Hess, M Salatino, DO Croci, JC Stupirski, ... Cancer Immunology, Immunotherapy 61, 469-480, 2012 | 8 | 2012 |
| INMUNOMODULACIÓN Y ANTIANGIOGÉNESIS EN LA TERAPÉUTICA ONCOLÓGICA DE LA INVESTIGACIÓN BÁSICA A LA CLÍNICA OG SCHAROVSKY, P MATAR, VR ROZADOS, MJ RICO, MFZ FLUCK, ... MEDICINA (Buenos Aires) 72 (1), 47-57, 2012 | 8 | 2012 |
| From immune surveillance to tumor-immune escape: the story of an enemy with multiple strategies OG Scharovsky, P Matar, MZ Fluck, MJ Rico, GA Rabinovich Inmunology 2006 25 (1), 101-14, 2006 | 8 | 2006 |
| A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting L Pagura, JM Cáceres, A Cardinale, OG Scharovsky, RJD Masso, ... Journal of Biomedical Science 21, 1-10, 2014 | 7 | 2014 |
| Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts B Morancho, M Zacarías-Fluck, A Esgueva, C Bernadó-Morales, ... Oncotarget 7 (42), 67956, 2016 | 5 | 2016 |
| Antiangiogenic and inmunomodulatory effect of the metronomic therapy with cyclophosphamide VR Rozados, LE Mainetti, MJ Rico, MF Zacarías Fluck, P Matar, ... Biocell 3, 119, 2007 | 4 | 2007 |
| Immunomodulation and antiangiogenesis in cancer therapy. From basic to clinical research OG Scharovsky, P Matar, VR Rozados, MJ Rico, ZF MF, LE Mainetti, ... Medicina 72 (1), 47-57, 2012 | 3 | 2012 |
| Low dose cyclophosphamide (Cy) treatment induces a decrease in the percentage of regulatory T cells in lymphoma-bearing rats M Rico, P Matar, M Zacarias Fluck, R Giordano, OG Scharovsky Cancer Research 67 (9_Supplement), 967-967, 2007 | 3 | 2007 |
| Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma MF Zacarías-Fluck, D Massó-Vallés, F Giuntini, Í González-Larreategui, ... Genes & Development 37 (7-8), 303-320, 2023 | 1 | 2023 |
Jonathan WhitfieldSenior Investigator, VHIODirección de correo verificada de vhio.net
